Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Accounts Receivable (Quarterly): 14.65M for Sept. 30, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 14.65M |
June 30, 2023 | 10.52M |
March 31, 2023 | 6.227M |
December 31, 2022 | 0.865M |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | 0.00 |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 |
Date | Value |
---|---|
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | 0.1941M |
June 30, 2012 | 0.0442M |
March 31, 2012 | 0.1934M |
December 31, 2011 | |
September 30, 2011 | 0.1754M |
June 30, 2011 | 0.6298M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2021
14.65M
Maximum
Sep 2023
6.453M
Average
6.227M
Median
Mar 2023
Accounts Receivable (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 8.826B |
Karuna Therapeutics Inc (DELISTED) | 0.00 |
Puma Biotechnology Inc | 24.58M |
NovaBay Pharmaceuticals Inc | 0.734M |
Palatin Technologies Inc | 0.00 |